本页面由Tiger Trade Technology Pte. Ltd.提供服务

Y-mAbs Therapeutics, Inc.

8.61
0.0000
成交量:- -
成交额:654.34万
市值:3.91亿
市盈率:-17.40
高:8.61
开:8.61
低:8.61
收:8.61
52周最高:16.11
52周最低:3.55
股本:4,543.84万
流通股本:1,859.14万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-0.4948
每股收益(LYR):-0.6692
净资产收益率:-24.31%
总资产收益率:-8.67%
市净率:4.47
市盈率(LYR):-12.87

数据加载中...

2025/09/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/16

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/16

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/09/16

重要事件披露

Form 8-K - Current report
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report
2025/08/05

重要事件披露

Form 8-K - Current report
2025/07/15

重要事件披露

Form 8-K - Current report
2025/05/28

重要事件披露

Form 8-K - Current report
2025/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

重要事件披露

Form 8-K - Current report
2025/04/29

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/03/05

重要事件披露

Form 8-K - Current report
2025/03/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans